FS Development Holdings, LLC 4
4 · Gemini Therapeutics, Inc. /DE · Filed Feb 9, 2021
Insider Transaction Report
Form 4
FS Development Holdings, LLC
10% Owner
Transactions
- Award
Common Stock
2021-02-05$10.00/sh+1,500,000$15,000,000→ 1,500,000 total - Conversion
Common Stock
2021-02-05+2,928,750→ 2,928,750 total - Conversion
Common Stock
2021-02-05−2,928,750→ 0 totalExercise: $0.00→ Common Stock (2,928,750 underlying)
Holdings
- 441,500
Common Stock
Footnotes (3)
- [F1]Shares of common stock obtained in private placement of public securities ("PIPE") on February 5, 2021.
- [F2]These shares of the Issuer's common stock are held of record by FS Development Holdings, LLC ("FSD Holdings"). Foresite Capital Management V LLC ("FCMVLLC") and Foresite Capital Opportunity Management V, LLC ("FCOMVLLC") are general partners, respectively, of Foresite Capital Fund V, L.P. ("Capital Fund V L.P.") and Foresite Capital Opportunity Fund V, L.P. ("Opportunity Fund V .L.P."), the sole shareholders of FSD Holdings. Each of FCMVLLC, FCOMVLLC, Capital Fund V L.P and Opportunity Fund V L.P. disclaims beneficial ownership of these shares except to the extent of any pecuniary interest therein.
- [F3]In connection with the closing of Gemini Therapeutics, Inc.'s (formerly known as FS Development Corp.) business combination, shares of Class B Common Stock of FS Development Corp. converted into common stock of the Issuer .